DOAC compared with warfarin for VTE in low weight patients: A retrospective cohort study conducted through the VENUS network

Thromb Res. 2023 Sep:229:146-148. doi: 10.1016/j.thromres.2023.07.004. Epub 2023 Jul 11.
No abstract available

Keywords: Anticoagulants; Body mass index; Factor Xa inhibitors; Thinness; Venous thromboembolism; Warfarin.

Publication types

  • Letter

MeSH terms

  • Administration, Oral
  • Anticoagulants / therapeutic use
  • Factor Xa Inhibitors / therapeutic use
  • Humans
  • Retrospective Studies
  • Rivaroxaban / therapeutic use
  • Venous Thromboembolism* / drug therapy
  • Warfarin* / therapeutic use

Substances

  • Warfarin
  • Anticoagulants
  • Rivaroxaban
  • Factor Xa Inhibitors